Canada Pension Plan Investment Board’s Mirum Pharmaceuticals MIRM Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$813K	Sell	8,800 -24,896	-74%	-$2.34M	﹤0.01%	1067
2025 Q4	$2.66M	Buy	33,696 +13,000	+63%	+$933K	﹤0.01%	887
2025 Q3	$1.52M	Buy	+20,696	New	+$1.32M	﹤0.01%	958
2025 Q1	–	Sell	-41,800	Closed	-$1.73M	–	1414
2024 Q4	$1.73M	Buy	+41,800	New	+$1.74M	﹤0.01%	906

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Canada Pension Plan Investment Board's MIRM Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Mirum Pharmaceuticals (MIRM) stake by 74% in Q1 2026, selling an estimated $2.34M and leaving 8,800 shares worth $813K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Canada Pension Plan Investment Board first reported a position in MIRM in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.66M in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

Canada Pension Plan Investment Board held 8,800 shares of Mirum Pharmaceuticals worth $813K as of Q1 2026.
Canada Pension Plan Investment Board sold 24,896 Mirum Pharmaceuticals shares in Q1 2026, an estimated $2.34M.
Mirum Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1067 holding.
Canada Pension Plan Investment Board first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
Canada Pension Plan Investment Board's Mirum Pharmaceuticals position peaked at $2.66M in Q4 2025.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.